Please login to the form below

Not currently logged in


This page shows the latest cobimetinib news and features for those working in and with pharma, biotech and healthcare.

Amgen's Mvasi is first FDA-approved cancer biosimilar

Amgen's Mvasi is first FDA-approved cancer biosimilar

Roche is also in the midst of a fertile launch period for new medicines, with a clutch of new drugs - including Cotellic (cobimetinib) for melanoma, Alecensa (alectinib) for lung cancer, leukaemia

Latest news

More from news
Approximately 5 fully matching, plus 16 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Brandcast Health

Brandcast Health is a digital MedComms and patient-engagement agency who help our clients create and share engaging content. Our innovative...

Latest intelligence

Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....